Here the authors show that inappropriate activation of latent TGF-β in murine, bovine and human lung by monocyte-produced TSP-1 causes pulmonary hypertension, and that interference with the activation process prevents disease development. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.